Moderna, Inc. vs Nicox SA
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $61 M for Nicox SA, 1478 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Dec 25, 2022 for Nicox SA). Nicox SA's value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.
- Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $9 M for Nicox SA in the year to December 2021.
- Both made a net loss: $2.8 B for Moderna, Inc. and $52 M for Nicox SA.
- Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -605.1% for Nicox SA.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Moderna, Inc. MRNA · #275 in the world | Nicox SA COX.PA |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇫🇷 France |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2010 | — |
| Size | ||
| Market cap | $90.1 B | $61 M* |
| Revenue | $1.9 B | $9 M |
| Net income | $-2.8 B | $-52 M▲ best |
| Employees | 4,700 | — |
| Valuation | ||
| Price to sales | 35.7× | — |
| Price to book | 10.4× | — |
| Free cash flow yield | -2.3% | — |
| Profitability | ||
| Gross margin | 55.4% | — |
| Operating margin | -158.1% | — |
| Net margin | -145.2% | — |
| Return on equity | -28.9% | — |
| Growth | ||
| Revenue growth | -39.9% | — |
| Revenue growth, 3 years a year | -53.4% | — |
| Financial strength | ||
| Debt to equity | 0.1× | — |
| Cash | ||
| Free cash flow margin | -106.2% | — |
| Shareholder returns | ||
| Shareholder yield | 0.0% | — |
| Strength scores | ||
| Piotroski F-score | 3 of 9 | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Dec 2022 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Moderna, Inc. or Nicox SA?
Moderna, Inc. is the larger company by market value: $90.1 B against $61 M for Nicox SA, 1478 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Dec 25, 2022 for Nicox SA). Nicox SA's value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.
Which makes more money, Moderna, Inc. or Nicox SA?
Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $9 M for Nicox SA in the year to December 2021. Both made a net loss: $2.8 B for Moderna, Inc. and $52 M for Nicox SA.
Which is more profitable, Moderna, Inc. or Nicox SA?
Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -605.1% for Nicox SA.
More about Moderna, Inc.
More about Nicox SA
Sources#
Every figure on this page comes from these, with the date shown next to it.